Mi Hwa Heo

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Yoon‐Koo Kang, Jeong Hwan Yook, Young-Kyu Park et al. · Journal of Clinical Oncology · 2021 · 332 citations · Full text

Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors

Hee Kyung Kim, Mi Hwa Heo, Han Sang Lee et al. · Cancer Chemotherapy and Pharmacology · 2017 · 56 citations

Cancer Immunosurveillance, Immune-checkpoint Inhibitors, Medicine +10

Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY

Yoon‐Koo Kang, Hyung‐Don Kim, Jeong Hwan Yook et al. · Journal of Clinical Oncology · 2024 · 34 citations

The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC)

Mi Hwa Heo, Hee Kyung Kim, Hansang Lee et al. · Journal of Cancer · 2017 · 29 citations · Full text

Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer

Jin Young Kim, Won Young Jang, Mi Hwa Heo et al. · Cancer Research and Treatment · 2012 · 27 citations · Full text